サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1660696

組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2025年～2033年

Tissue Diagnostics Market Report by Product Type, Technology, Disease, End-User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
組織診断市場レポート：製品タイプ、技術、疾患、エンドユーザー、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組織診断の世界市場規模は2024年に58億米ドルに達しました。今後、IMARC Groupは、2033年には98億米ドルに達し、2025-2033年の成長率（CAGR）は5.64%になると予測しています。

組織診断には、疾患の生物学的背景を捉えることによる特定の組織サンプルの分析と検査が含まれます。がんや炎症性疾患のような特定の病状を検出するために使用され、悪性腫瘍の正確な種類と程度を明らかにすることで、潜在的な原因や治療法を特定するのに役立ちます。組織診断は非常に正確で安価であり、コア生検や開腹生検といった様々な手法で実施することができます。最近では、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、デジタルパソロジー、特殊染色などの高度な技術もこれらの診断に用いられています。

出生率の低下と平均余命の伸びにより、老年人口の全体的な割合は現在世界中で着実に増加しています。高齢者は慢性疾患にかかりやすいため、頻繁な検査と診断が必要となります。これとは別に、食事パターンの変化、アルコール消費量の増加、身体活動の低下などが、いくつかの生活習慣病の発生率の上昇につながっています。これに加えて、あらゆる年齢層で様々な種類のがんの有病率が上昇していることも、こうした診断サービスに対する需要の急増につながっています。

本レポートで扱う主な質問

  • 世界の組織診断の市場の市場規模は？
  • 2025-2033年における世界の組織診断の市場の予想成長率は？
  • 世界の組織診断の市場を牽引する主要因は何か？
  • 世界の組織診断の市場に対するCOVID-19の影響は？
  • 世界の組織診断の市場の製品タイプ別内訳は？
  • 世界の組織診断の市場の技術別内訳は？
  • 世界の組織診断の市場の疾患別内訳は？
  • 世界の組織診断の市場のエンドユーザー別の内訳は？
  • 世界の組織診断の市場における主要地域は？
  • 世界の組織診断の市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の組織診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品タイプ別
  • 市場内訳：技術別
  • 市場内訳：疾患別
  • 市場内訳：エンドユーザー別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 機器
    • 市場動向
    • 市場予測
  • 消耗品
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • 免疫組織化学
    • 市場動向
    • 市場予測
  • In Situハイブリダイゼーション
    • 市場動向
    • 市場予測
  • デジタル病理学とワークフロー管理
    • 市場動向
    • 市場予測
  • 特殊染色
    • 市場動向
    • 市場予測

第8章 市場内訳：疾患別

  • 乳がん
    • 市場動向
    • 市場予測
  • 胃がん
    • 市場動向
    • 市場予測
  • リンパ腫
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • 非小細胞肺がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 研究ラボ
    • 市場動向
    • 市場予測
  • 製薬会社
    • 市場動向
    • 市場予測
  • 受託研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • アジア太平洋地域
    • 市場動向
    • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Roche
    • Danaher
    • Thermo Fisher Scientific
    • Abbott
    • Agilent Technologies
    • Merck
    • Sakura Finetek Japan
    • Abcam
    • BD
    • Qiagen
    • Bio SB
    • Biogenex
    • Cell Signaling Technology
図表

List of Figures

  • Figure 1: Global: Tissue Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Tissue Diagnostics Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Tissue Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Tissue Diagnostics Market: Breakup by Disease (in %), 2024
  • Figure 6: Global: Tissue Diagnostics Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Tissue Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Tissue Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Tissue Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Tissue Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Tissue Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 12: Global: Tissue Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Tissue Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Tissue Diagnostics (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Tissue Diagnostics (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Tissue Diagnostics (Immunohistochemistry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Tissue Diagnostics (Immunohistochemistry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Tissue Diagnostics (In Situ Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Tissue Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Tissue Diagnostics (Digital Pathology and Workflow Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Tissue Diagnostics (Special Staining) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Tissue Diagnostics (Special Staining) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Tissue Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Tissue Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Tissue Diagnostics (Gastric Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Tissue Diagnostics (Gastric Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Tissue Diagnostics (Lymphoma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Tissue Diagnostics (Lymphoma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Tissue Diagnostics (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Tissue Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Tissue Diagnostics (Non-Small Cell Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Tissue Diagnostics (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Tissue Diagnostics (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Tissue Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Tissue Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Tissue Diagnostics (Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Tissue Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Tissue Diagnostics (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Tissue Diagnostics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Tissue Diagnostics (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Tissue Diagnostics (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Tissue Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Tissue Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: North America: Tissue Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: North America: Tissue Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Tissue Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Tissue Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Asia Pacific: Tissue Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Asia Pacific: Tissue Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Middle East and Africa: Tissue Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Middle East and Africa: Tissue Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Latin America: Tissue Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Latin America: Tissue Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Tissue Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Tissue Diagnostics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Tissue Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Tissue Diagnostics Market Forecast: Breakup by Disease (in Million USD), 2025-2033
  • Table 5: Global: Tissue Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Tissue Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Tissue Diagnostics Market Structure
  • Table 8: Global: Tissue Diagnostics Market: Key Players
目次
Product Code: SR112025A1349

The global tissue diagnostics market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

Breakup by Product Type:

  • Instruments
  • Consumables

Breakup by Technology:

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Breakup by Disease:

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Key Questions Answered in This Report

  • 1.How big is the global tissue diagnostics market?
  • 2.What is the expected growth rate of the global tissue diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global tissue diagnostics market?
  • 4.What has been the impact of COVID-19 on the global tissue diagnostics market?
  • 5.What is the breakup of the global tissue diagnostics market based on the product type?
  • 6.What is the breakup of the global tissue diagnostics market based on the technology?
  • 7.What is the breakup of the global tissue diagnostics market based on the disease?
  • 8.What is the breakup of the global tissue diagnostics market based on the end-user?
  • 9.What are the key regions in the global tissue diagnostics market?
  • 10.Who are the key players/companies in the global tissue diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Technology
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunohistochemistry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 In Situ Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Digital Pathology and Workflow Management
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Special Staining
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Breast Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lymphoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Non-Small Cell Lung Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Contract Research Organizations
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Roche
    • 15.3.2 Danaher
    • 15.3.3 Thermo Fisher Scientific
    • 15.3.4 Abbott
    • 15.3.5 Agilent Technologies
    • 15.3.6 Merck
    • 15.3.7 Sakura Finetek Japan
    • 15.3.8 Abcam
    • 15.3.9 BD
    • 15.3.10 Qiagen
    • 15.3.11 Bio SB
    • 15.3.12 Biogenex
    • 15.3.13 Cell Signaling Technology